Ashwini Shewade^1*, Adam J Olszewski, MD², Nelson Pace^1*, Andy Surinach, MPH^3*, Gila Sellam^4*, Lars Mueller^1* and Carol O’Hear^1*

¹Genentech, Inc., South San Francisco, CA
²Lifespan Cancer Institute, Warren Alpert Medical School of Brown University, Providence, RI
³Genesis Research, Hoboken, NJ
⁴F. Hoffmann-La Roche Ltd, Basel, Switzerland

Skander Jemaa^1*, Samuel Tracy^1*, Alessia Bottos^2*, Alex de Crespigny^1*, Thomas Bengtsson^1*, Tina G Nielsen^2* and Joseph N Paulson^1*

¹Genentech, Inc., South San Francisco, CA
²F. Hoffmann-La Roche Ltd, Basel, Switzerland

William B Pearse, MD¹, Chetan V Vakkalagadda, MD^2*, Irene Helenowski, PhD^3*, Jane N. Winter, MD⁴, Leo I. Gordon, MD⁵, Reem Karmali, MD, MSc⁶, Shuo Ma, MD, PhD⁵, Joseph R. Leventhal, MD, PhD^7*, John Friedewald, MD^8*, Daniel Ganger, MD^9* and Barbara Pro, MD⁵

¹Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
²Northwestern University Medical Center, Chicago, IL
³Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL
⁴Division of Hematology and Oncology, Northwestern University, Chicago, IL
⁵Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center, Chicago, IL
⁶Robert H. Lurie Comprehensive Cancer Center, Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL
⁷Feinberg School of Medicine, Northwestern University, Chicago, IL
⁸Comprehensive Transplant Center, Northwestern University Medical Center, Chicago, IL
⁹Northwestern Medicine Digestive Health Center, Northwestern University Medical Center, Chicago, IL

Danny Luan, MPH¹, Yiyuan Wu, MS^2*, Jordan S. Goldstein, MD, MSc³, Sarah C. Rutherford, MD⁴, John P. Leonard, MD^5,6 and Peter Martin, FRCPC, MD, MS⁴

¹Weill Cornell Medical College, New York, NY
²Department of Healthcare Policy & Research, Weill Cornell Medicine, New York, NY
³Department of Medicine, New York Presbyterian - Weill Cornell Medical Center, New York, NY
⁴Weill Cornell Medicine-New York Presbyterian Hospital, New York, NY
⁵Weill Cornell Medicine, New York, NY
⁶Weill Cornell Medical College, Pelham Manor, NY

Nora Liebers, MD^1,2*, Johannes Duell, MD^3*, Daniel Nörenberg, MD^4*, Eva Kaebisch, MD^4*, Andrea Kerkhoff, MD^5*, Fabian Acker, MD^6*, Stephan Fuhrmann, MD^7*, Corinna Leng, MD, PhD^8*, Manfred Welslau, MD^9*, Jens Chemnitz, MD^10*, Jan Moritz Middeke, MD^11*, Thomas Weber, MD^12*, Ralf Ulrich Trappe, MD^13*, Roald Pfannes, MD^14*, Ruediger Liersch, MD^15*, Christian Spoer, MD^16*, Niklas Gebauer, MD^17*, Stefan Fuxius, MD^18*, Léandra Caillé^1*, Christiane Pott, MD, PhD^19*, Christian Koenecke, MD^20*, Udo Holtick^21*, Thomas Geer, MD^22*, Ulrich Keller, MD^8*, Rainer Claus, MD^23*, Dimitrios Mougiakakos, MD^24*, Stephanie Mayer, MD^25*, Andreas Hüttmann, MD²⁶, Arne Trummer, MD^27*, Gerald Wulf, MD^28*, Uta Brunnberg, MD^6*, Lars Bullinger, MD²⁹, Georg Hess, MD^30*, Carsten Mueller-Tidow, MD^1,2*, Bertram Glass, MD^7*, Georg Lenz³¹, Peter Dreger, MD¹ and Sascha Dietrich, M.D.^1,2,32

¹Internal Medicine V - Hematology, Oncology & Rheumatology, University Hospital Heidelberg, Heidelberg, Germany
²National Center for Tumor Diseases Heidelberg, Heidelberg, Germany
³Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
⁴Department of Hematology, Oncology and Tumor Immunology (Campus Virchow-Klinikum), Charité University Medicine, Berlin, Germany
⁵Department of Medicine A, University Hospital Muenster, Muenster, Germany
⁶Department of Medicine 2, Hematology and Oncology, University Hospital Frankfurt, Frankfurt, Germany
⁷Department of Hematology, HELIOS Klinikum Berlin-Buch, Berlin, Germany
⁸Department of Hematology, Oncology, and Tumor Immunology (Campus Benjamin Franklin), Charité University Medicine, Berlin, Germany
⁹MVZ am Klinikum Aschaffenburg, Onkologie und Hämatologie, Aschaffenburg, Germany
¹⁰Gemeinschaftsklinikum Mittelrhein GmbH, Koblenz, Germany
¹¹University Hospital Dresden, Dresden, Germany
¹²Department of Medicine IV, Hematology and Oncology, University Hospital Halle, Halle, DEU
¹³Department of Hematology and Oncology, DIAKO Hospital Bremen, Bremen, Germany
¹⁴Department of Medicine I, Städtisches Klinikum Dessau, Dessau, Germany
¹⁵Gemeinschaftspraxis für Hämatologie und Onkologie, Muenster, Germany
¹⁶MVZ am EVK Düsseldorf, Internistische Onkologie und Hämatologie, Düsseldorf, Germany
¹⁷Department of Hematology and Oncology, University Hospital of Schleswig-Holstein, Campus Lübeck, Lübeck, Germany
¹⁸Onkologische Schwerpunktpraxis Heidelberg, Heidelberg, Germany
¹⁹Second Medical Department, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
²⁰Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
²¹Department of Internal Medicine I, Leukapheresis and Stem Cell Transplant Unit, University Hospital of Cologne, Cologne, Germany
²²Diakonie Klinikum Schwäbisch-Hall, Innere Medizin III, Schwäbisch-Hall, Germany
²³Hematology and Oncology, Medical Faculty, University of Augsburg, Augsburg, Germany
²⁴Department of Internal Medicine 5, Hematology and Oncology, University Hospital of Erlangen, Erlangen, Germany
²⁵Department of Internal Medicine III, University Hospital of Regensburg, Regensburg, Germany
²⁶Department of Hematology, University Hospital of Essen, Essen, Germany
²⁷Department of Hematology and Oncology, Klinikum Braunschweig, Braunschweig, Germany
²⁸Clinic for Hematology and Medical Oncology, University Medicine Göttingen, Goettingen, Germany
²⁹Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine Berlin, Berlin, Germany
³⁰Department of Hematology, Medical Oncology and Pneumology, Johannes Gutenberg University of Mainz, Mainz, Germany
³¹Department of Medicine A, University Hospital Muenster, Munster, Germany
³²European Molecular Biology Laboratory (EMBL), Heidelberg, Germany

Akram Alkrekshi, MD^1*, Ahmad Kassem, MD^2*, Changsu Park, MD^3* and William Tse, MD³

¹Department of Hematology and Oncology, The MetroHealth System campus of Case Western Reserve University, Westlake, OH
²Department of Hematology and Oncology, The MetroHealth System campus of Case Western Reserve University, Cleveland
³Department of Hematology and Oncology, The MetroHealth System campus of Case Western Reserve University, Cleveland, OH

Aparna Raval^1*, Samuel Tracy^1*, Jill Ray^1*, Hai Lin^2*, Alex Lovejoy^2*, Tina G Nielsen^3*, Joseph N Paulson^1*, Gila Sellam^3* and Anas Younes⁴

¹Genentech, Inc., South San Francisco, CA
²Roche Sequencing Solutions, Pleasanton, CA
³F. Hoffmann-La Roche Ltd, Basel, Switzerland
⁴Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York City, NY

Juan Pablo Alderuccio, MD¹, Russ A Kuker, MD^2*, Priscila Barreto-Coelho, MD^3*, Bianca Marie Martinez, BS^3*, Feng Miao, MS^4*, Amer Beitinjaneh, MD, MPH, MSc^5*, Trent Peng Wang, DO^6*, Isildinha M Reis, PhD^7*, Izidore S. Lossos, MD¹ and Craig H. Moskowitz, MD⁸

¹Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, FL
²University of Miami Miller School of Medicine, Miami
³University of Miami, Miami
⁴University of Miami School of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL
⁵Adult Stem Cell Transplant Program / Division of Hematology / Department of Medicine, Sylvester Comprehensive Cancer Center / University of Miami Leonard M. Miller School of Medicine, Miami, FL
⁶Sylvester Comprehensive Cancer Center, University of Miami, Miami
⁷Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
⁸Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL

Brian T. Hess, MD¹, Anshu Giri, MD^2*, Yeonhee Park, PhD^1*, Krina K. Patel, M.D.³, Brian K. Link, MD⁴, Grzegorz S. Nowakowski, MD⁵, Seth M Maliske, MD⁴, Sonia Fortin^5*, Julio C. Chavez, MD⁶, Hayder Saeed, MD⁷, Brian T. Hill, MD⁸, Alex V. Mejia Garcia, MD⁹, Kami J. Maddocks, MD¹⁰, Walter Hanel, MD^10*, Nina D. Wagner-Johnston¹¹, Marcus Raymond Messmer, MD^11*, Brad S. Kahl, MD¹², Marcus Watkins, PhD^13*, Juan Pablo Alderuccio, MD¹⁴, Izidore S. Lossos, MD¹⁴, Sunita Nathan, MD¹⁵, Victor M. Orellana-Noia, MD¹⁶, Craig A. Portell, MD¹⁷, Daniel J. Landsburg, MD¹⁸, Emily C. Ayers, MD¹⁹ and Jorge J. Castillo, MD²⁰

¹Hollings Cancer Center, Medical University of South Carolina, Charleston, SC
²Fox Chase Cancer Center, Philadelphia, PA
³Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
⁵Mayo Clinic, Rochester, MN
⁶Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
⁷Dept. of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
⁸Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, OH
⁹Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH
¹⁰Ohio State University Hospital, Columbus, OH
¹¹Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore, MD
¹²Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
¹³Barnes-Jewish Hospital, Washington University in St. Louis, St. Louis, MO
¹⁴Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, FL
¹⁵Rush University Medical Center, Chicago, IL
¹⁶Winship Cancer Institute, Emory University, Atlanta, GA
¹⁷Division of Hematology/Oncology, University of Virginia, Charlottesville, VA
¹⁸Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
¹⁹Division of Hematology/Oncology, University of Virginia School of Medicine, Charlottesville, VA
²⁰Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Aaron M Goodman, MD^1*, Kimberly A Holden^2*, Ah-Reum Jeong, MD^3,4, Lisa Kim^5*, Kerry D Fitzgerald, PhD^2*, Eyad Almasri, PhD^2*, Graham McLennan^2*, Marcia Eisenberg, PhD^6,7*, Amin H Jahromi^5*, Carl Hoh^5*, Michael Hurley^8*, Carolyn Mulroney, MD⁹, Dimitrios Tzachanis, MD, PhD^4,10, Edward D. Ball, MD^11*, Taylor J Jensen, PhD, BS^12,13* and Razelle Kurzrock, MD^14*

¹Department of Medicine, Division of Blood and Marrow Transplantation, University of California San Diego, La Jolla, CA
²Sequenom, Inc.,a wholly owned subsidiary of Laboratory Corporation of America® Holdings, San Diego, CA
³Department of Medicine, Division of Hematology and Oncology, University of California San Diego, La Jolla, CA
⁴Moores Cancer Center, University of California San Diego, La Jolla, CA
⁵University of California, San Diego, Moores Cancer Center, La Jolla, CA
⁶Laboratory Corporation of America, Burlington, NC
⁷Laboratory Corporation of America, Durham, NC
⁸University of California San Diego, San Diego
⁹UCSD Moores Cancer Center, La Jolla, CA
¹⁰Moores Cancer Center, University of California San Diego, San Diego
¹¹BMT Division, Department of Medicine, University of California, San Diego, La Jolla, CA
¹²Research and Development, Laboratory Corporation of America, Durham, NC
¹³Sequenom,Inc., a wholly owned subsidiary of Laboratory Corporation of America, San Diego, CA
¹⁴Department of Medicine, Division of Hematology and Oncology, Center for Personalized Cancer Therapy, University of California San Diego, La Jolla, CA

Nicole Chien, MBBChir^1*, Diego Villa, MD MPH², Ciara L. Freeman, MSc, MBBChir², Graham W. Slack, MD³, Kerry J. Savage, BSc, MD, MSc², David W. Scott, MBChB, PhD², Laurie H. Sehn, MD, MPH⁴, Kevin W Song, MD, FRCPC⁵ and Alina S. Gerrie, MD, MPH²

¹Leukemia/Bone Marrow Transplant Program of British Columbia, Vancouver General Hospital, Auckland, New Zealand
²BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC, Canada
³Department of Histopathology, BC Cancer Agency, Vancouver, BC, Canada
⁴BC Cancer Centre for Lymphoid Cancer, University of British Columbia, vancouver, BC, Canada
⁵Leukemia/Bone Marrow Transplant Program of British Columbia, Vancouver General Hospital, Vancouver, BC, Canada

Elise A. Chong, MD¹, Emeline R. Chong^1*, Daniel J. Landsburg, MD¹, James N. Gerson, MD¹, Jakub Svoboda, MD¹, Sunita Dwivedy Nasta, MD¹, Stefan K. Barta, MD, MRCP, MS¹, Alfred L. Garfall, MD², Elizabeth Weber, BSN, RN^3*, Marco Ruella, MD^1,4, Noelle V. Frey, MD, MS⁵, David L. Porter, MD⁶ and Stephen J. Schuster, MD¹

¹Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
²Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
³Cell Therapy and Transplantation, University of Pennsylvania, Philadelphia
⁴Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
⁵Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia
⁶Cell Therapy and Transplantation, University of Pennsylvania, Philadelphia, PA

Vincent Camus^1*, Alina Berriolo-Riedinger^2*, Justine Lequesne^3*, David Tonnelet, MD^4*, Pierre Decazes^4*, Cédric Rossi, MD, PhD^5*, Pierre Sesques, MD^6*, Corinne Haioun, MD, PhD^7*, Eric Durot, MD^8*, Alexandre Willaume^9*, Martin Gauthier^10*, Marie-Pierre Moles, MD^11*, Chloe Antier^12*, Julien Lazarovici, MD^13*, Helene Monjanel^14*, Sophie Bernard^15*, Magalie Tardy^16*, Caroline Besson, MD, PhD¹⁷, Laure Lebras, MD^18*, Choquet Sylvain^19*, Katell Le Du, MD^20*, Christophe Bonnet, MD^21*, Sarah Bailly, MD^22*, Damaj Gandhi Laurent, MD, PhD^23*, Kamel Laribi, MD^24*, Herve Maisonneuve, MD²⁵, Roch Houot, MD, PhD^26*, Adrien Chauchet, MD^27*, Fabrice Jardin, MD, PhD^1*, Stephanie Becker, MD^28* and Herve Tilly, MD, PhD⁴

¹Department of Hematology, Centre Henri Becquerel, Rouen, France
²CGFL, Dijon, France
³Centre Henri Becquerel, Rouen, FRA
⁴Centre Henri Becquerel, Rouen, France
⁵Hematology Department, University Hospital F. Mitterrand and Inserm UMR 1231, Dijon, France
⁶Department of Hematology, Lyon-Sud Hospital, Pierre-Benite, France
⁷Lymphoid Malignancies Unit, Henri Mondor University Hospital, APHP, Créteil, France
⁸CHU Reims, Hôpital Robert Debré, Reims, France
⁹Service des Maladies du Sang, CHU Lille, Lille, France
¹⁰Hematology Department, IUC Toulouse Oncopole, Toulouse, France
¹¹Hematology Department, Angers Hospital, Angers, France
¹²Department of Hematology, Nantes University Hospital, Nantes, France
¹³Department of hematology, Gustave Roussy Cancer Campus Grand Paris, Villejuif CEDEX, France
¹⁴Clermont-Ferrand University Hospital, Clermont-Ferrand, France
¹⁵Assistance Publique Hôpitaux de Paris - Hopital Saint-Louis, Paris, Paris, France
¹⁶Centre Antoine Lacassagne, Nice, France
¹⁷Centre Hospitalier de Versailles, Le Chesnay, France
¹⁸Hematology, Centre Leon Berard, Lyon, France
¹⁹Pitie-Salpetriere Hospital, Paris, FRA
²⁰Department of Hematology, Clinique du Mans, Le Mans, France
²¹Department of Hematology, CHU Liege, Liege, Belgium
²²Cliniques Universitaires Saint-Luc, Brussels, Belgium
²³CHU Caen, Caen, France
²⁴Centre Hospitalier Du Mans, Le Mans, France
²⁵Clinical Hematology, Centre Hospitalier Départemental Vendée, La Roche-sur-Yon, France
²⁶Hematology Department, CHU Rennes, Rennes, France
²⁷Hematology Department, Besancon University Hospital, Besancon, France
²⁸Department of Nuclear Medicine, Centre Henri Becquerel, Rouen, France

Mazie Tsang, MD¹, Joseph Cleveland, MD^2*, Miguel Carlos Cerejo, DO^3*, Huimin Geng, Ph.D.⁴ and James L. Rubenstein, MD, PhD¹

¹Hematology/Oncology, UCSF, San Francisco, CA
²University of California, San Francisco, San Francisco, CA
³Division of Hematology and Blood and Marrow Transplantation, University of California San Francisco, San Francisco, CA
⁴Department of Laboratory Medicine, UCSF, San Francisco, CA

Jonathan Siglin, BS^1*, Forat Lutfi, MD², Ali Bukhari, MD², Noa G. Holtzman, MD³, Dong Won Kim, MD^3*, Moaath Mustafa Ali, MD, MPH^2*, Aaron P. Rapoport, MD³ and Saurabh Dahiya, MD³

¹University of Maryland School of Medicine, Baltimore, MD
²Division of Hematology and Oncology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
³University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD

Loïc Renaud, MD, MSc^1*, Jean-Baptiste Bossard, MD, MSc^1*, Louis Terriou^2*, Nathalie Cambier, MD^3*, Guillaume Chanteau^1*, Benjamin Carpentier, MD^4*, Sarah Barbieux, MD^5*, Mathieu Wemeau, MD^6*, Julia Hieulle^1*, Eileen M Boyle, MD, MSc⁷ and Franck Morschhauser, MD, PhD^1*

¹Service des Maladies du Sang, Centre Hospitalier Régional Universitaire De Lille, Lille, France
²Clinical immunology department, CHU Lille, Lille, France
³Hématologie Clinique, Centre Hospitalier de Valenciennes, Valenciennes, France
⁴Hopital Saint Vincent, GHICL, Lille, FRA
⁵Hématologie Clinique, Centre Hospitalier de Dunkerque, Dunkerque, France
⁶Hématologie Clinique, Centre Hospitalier de Roubaix, Roubaix, France
⁷Myeloma Research Program, Perlmutter Cancer Center, NYU Langone Health, New York, NY

Mohammad Ahsan Sohail, MD^1*, Hong Li^2*, Wei Wei, MS^2*, Sebastian Cerdena, PharmD^3*, Marcus Watkins, PhD^3*, Marissa Olson, PharmD^3*, Gray Jodon, MD⁴, Jeff Kaiser, PharmD^4*, Bradley Haverkos, MD, MPH, MS^4*, Mitchell E. Hughes, PharmD^5*, Natalie S Grover, MD⁶, Anson Snow, MD⁶, Victor M. Orellana-Noia, MD⁷, Magdalena A Rainey, MS¹, Matthew J Cortese, MD, MPH⁸, Joslyn Rudoni, PharmD^9*, Craig A. Portell, MD¹⁰, Timothy J Voorhees, MD⁶, Daniel J. Landsburg, MD⁵, Manali Kamdar, MD, MDDS^4*, Brad S. Kahl, MD¹¹ and Brian T. Hill, MD¹²

¹Cleveland Clinic, Cleveland, OH
²Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH
³Barnes-Jewish Hospital, Washington University in St. Louis, St. Louis, MO
⁴University of Colorado Cancer Center, Aurora, CO
⁵Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁶Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
⁷Winship Cancer Institute, Emory University, Atlanta, GA
⁸Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH
⁹Department of Pharmacy, Cleveland Clinic, Cleveland, OH
¹⁰Division of Hematology/Oncology, University of Virginia, Charlottesville, VA
¹¹Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
¹²Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, OH

Carsten Henneges^1*, Dexter X Jin^2*, Jeffrey M Venstrom^2*, Sally E Trabucco, PhD³, Tina G Nielsen^4*, Elicia M. Penuel^1*, Sarah Huet^5*, Gilles Salles, MD, PhD⁵ and Joseph N Paulson^1*

¹Genentech, Inc., South San Francisco, CA
²Foundation Medicine, Inc., Cambridge, MA
³Foundation Medicine, Inc, Cambridge, MA
⁴F. Hoffmann-La Roche Ltd, Basel, Switzerland
⁵Centre Hospitalier Universitaire de Lyon, Lyon, France

Gloria Iacoboni, MD^1,2,3*, Marc Simo, MD^4*, Guillermo Villacampa^5,6*, Eva Catala^3,7*, Cecilia Carpio, MD^1,2,3*, Candido Diaz-Lagares, MD^8*, Angela Vidal-Jordana, MD^9*, Sabela Bobillo, MD^2,3,10*, Ana Marin-Niebla, MD, PhD^2*, Ana Perez, MD^2,11*, Moraima Jiménez^2,3*, Pau Abrisqueta, MD, PhD^1,2,3*, David Valcárcel, MD, PhD^1,2,3, Francesc Bosch, MD, PhD^1,3,11 and Pere Barba, MD, PhD^1,2,3*

¹Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain
²Department of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain
³Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
⁴Department of Nuclear Medicine. Vall D'Hebron University Hospital, Barcelona., Barcelona, ESP
⁵Oncology Data Science (ODysSey) Group, Vall d´Hebron Institute of Oncology, Barcelona, Spain
⁶SOLTI Breast Cancer Research Group, Barcelona, Spain
⁷Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Barcelona, Spain
⁸Department of Intensive Care, Vall d´Hebron University Hospital, Shock, Organ Dysfunction and Resuscitation (SODIR) Research Group, Vall d´Hebron Research Institute (VHIR), Barcelona, Spain
⁹Neurology-Neuroimmunology Department, Multiple Sclerosis Centre of Catalonia (Cemcat), Vall d’Hebron University Hospital, Barcelona, Spain
¹⁰Department of Medicine, Universitat Autònoma de Barcelona, 08193 Bellaterra, Barcelona, Spain
¹¹Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain

Fei Yang, MBBS, MMSc, PhD^1*, Anup Abraham, MPH^2*, Ju Zhang, MSPH, PhD^3*, Yan Xiao, MD, PhD^3*, Richard D. Hammer, MD^4*, Donald C. Doll, MD^4,5 and Matthew S. Prime, BSc, MBBS, MRCS, PhD^1*

¹Roche Diagnostics Information Solutions, Basel, Switzerland
²Genesis Research, Hoboken, NJ
³Roche Diagnostics Information Solutions, Belmont, CA
⁴University of Missouri, Columbia, MO
⁵Ellis Fischel Cancer Center, Columbia, MO

Arushi Khurana, MBBS¹, Abdullah S. Al Saleh, MBBS², Sangeetha Gandhi, MBBS^1*, Tuan A Truong^3*, Nabila Nora Bennani, MD³, Jonas Paludo, MD¹, Jose C Villasboas, MD³, Patrick B. Johnston, MD/ PhD³, Stephen M. Ansell, MD, PhD⁴ and Yi Lin, MD, PhD¹

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Mayo Clinic Rochester, Division of Hematology, Rochester, MN
³Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
⁴Mayo Clinic, Rochester, MN

Qinli Ma, PhD^1*, Ying Liu, PhD^1*, John Barron, PharmD^1*, David Debono, MD^2* and Michael Fisch, MD^3*

¹HealthCore, Wilmington, DE
²Anthem, Inc., Bloomfield Hills, MI
³AIM Specialty Health, Chicago, IL

Anna Purdum, PharmD, MS^1*, Jonathan Johnson^2*, Anthony Bonagura^3*, Liliosa Nyamutswa, MPH^4*, Caitlin Elliott, MS^5* and Lincy S. Lal, PhD⁶

¹Kite, A Gilead Company, Santa Monica, CA
²Optum Life Sciences, Eden Prairie, MN
³Optum, Minneapolis, MN
⁴Kite, Santa Monica, CA
⁵Optum, Eden Prairie, MN
⁶Optum, Missouri City, TX

Pietro R Di Ciaccio, BA/LLB MBBS^1,2, Fengyi Jin^3*, Matthew Law, BA, MSc, PhD^3*, Marina Van Leeuwen, PhD^4*, Andrew Grulich, MBBS, PhD^3*, Janaki Amin, BSc, MPH, PhD^3*, Claire Vajdic, PhD^4*, Skye McGregor, MA, PhD^3* and Mark N. Polizzotto, MBBS, PhD^1,3*

¹Department of Haematology, St Vincent's Hospital, Sydney, NSW, Australia
²University of New South Wales, Sydney, NSW, Australia
³The Kirby Institute, University of New South Wales, Sydney, NSW, Australia
⁴Cancer Epidemiology Research Unit, University of New South Wales, Sydney, NSW, Australia

Fernando Martin Moro, MD^1*, Miguel Piris-Villaespesa, MD^2*, Juan Marquet Palomanes^3*, Claudia Lopez Prieto^4*, Federico Santiago Herrera^4*, Maria Isabel Delgado Trillo, PhD^4*, Monica Garcia-Cosio, MD^5*, Alberto Martinez Lorca^6*, Ana Lario Arribas, MD^2*, Ernesto Roldan Santiago^7*, Eulalia Rodriguez Martin^7*, Jose A. Garcia-Marco Sr., MD, PhD⁸, Javier Lopez Jimenez, MD, PhD^3* and Jose Antonio Garcia Vela, MD^9*

¹Hematology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain
²Hematology and Hemotherapy, Hospital Universitario Ramón y Cajal, Madrid, Spain
³Hospital Universitario Ramón y Cajal, Madrid, Spain
⁴Hospital Universitario de Getafe, Madrid, Spain
⁵Anatomical Pathology Department, Hospital Universitario Ramón y Cajal, CIBERONC, Madrid, Spain
⁶Nuclear Medicine, Hospital Universitario Ramón y Cajal, Madrid, Spain
⁷Immunology, Hospital Universitario Ramón y Cajal, Madrid, Spain
⁸Puerta de Hierro-Majadahonda University Hospital, Madrid, Spain
⁹Hematology Department, Hospital Universitario de Getafe, Madrid, Spain

Veit Buecklein, MD^1,2*, Viktoria Blumenberg, MD^1,2*, Josephine Ackermann^1*, Christian Schmidt, MD^1*, Kai Rejeski, MD^1,2*, Niklas Mueller, MD^1,2*, Anna Reischer, MD^1,2*, Louisa von Baumgarten, MD^3*, Florian Schoeberl, MD^3*, Andreas Humpe, MD^4*, Michael von Bergwelt, MD, PhD^1,5* and Marion Subklewe, MD^1,2,5

¹Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
²Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany
³Department of Neurology, University Hospital, LMU Munich, Munich, Germany
⁴Department of Transfusion Medicine, Cell Therapeutics and Hemostaseology, University Hospital, LMU Munich, München, Germany
⁵German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany

Vinit Singh, MD^1*, Pooja Agrawal^2*, Varsha Gupta, MD³, Amulya Prakash, MD^1* and Doantrang T. Du, MD^4*

¹Monmouth Medical Center, Long Branch, NJ
²Golden Gate University, San Fransico, CA
³Jersey shore university medical center, Neptune, NJ
⁴Monmouth Medical Center an affiliate of RWJ/Barnabas health system, Long Branch, NJ

Diwen Pang^*, Xinmiao Jiang, MD^*, Ling Huang, MD^*, Yan Teng^*, Sichu Liu, MD^*, Feili Chen^*, Xiaojuan Wei^*, Hanguo Guo^* and Wenyu Li, PhD

Department of Lymphoma, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China

Bryan Valcarcel, MD^1*, Daniel J Enriquez, MD^2,3, Gustavo Sandival Ampuero, MD², Ursula Aviles-Perez^4*, Juan C Haro, MD^5*, Cindy Alcarraz, MD^2*, Shirley Quintana, MD^2*, Marco Villena, MD^2*, Daniela Dueñas, MD^2*, Sandro Casavilca, MD^2*, Carlos Barrionuevo, MD^2*, Cesar Samanez-Figari, MD^6* and Luis E Malpica Castillo, MD⁷

¹Milken Institute School of Public Health, The George Washington University, Washington
²Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru
³Universidad Privada San Juan Bautista, Lima, Peru
⁴Universidad Nacional Federico Villareal, Lima, Peru
⁵Medical Oncology, Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru
⁶Oncosalud - AUNA, Lima, Peru
⁷Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX